Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Geron Corporation    GERN

Delayed Quote. Delayed  - 02/10 03:59:59 pm
2.58 USD   -2.27%
07:31a Geron to Present at the RBC Capital Markets Healthcare Conference
01/15 GERON : Announces Initiation of Janssen Phase 2/3 Clinical Trial of ..
01/14 Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/04/2016 02/05/2016 02/08/2016 02/09/2016 02/10/2016 Date
2.95(c) 2.86(c) 2.615(c) 2.64(c) 2.58 Last
2 569 934 2 107 075 3 442 130 2 458 546 1 974 506 Volume
+1.72% -3.05% -8.57% +0.96% -2.27% Change
More quotes
Financials ($)
Sales 2015 36,5 M
EBIT 2015 -1,99 M
Net income 2015 -0,56 M
Debt 2015 142 M
Yield 2015 -
Sales 2016 15,1 M
EBIT 2016 -23,2 M
Net income 2016 -23,4 M
Debt 2016 -
Yield 2016 -
P/E ratio 2015 660,00
P/E ratio 2016
Capi. / Sales 2015 15,4x
Capi. / Sales 2016 27,6x
Capitalization 418 M
More Financials
Company
Geron Corp. discovers and develops therapeutic products for cancer.It is a clinical stage biopharmaceutical company developing a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.The company's imetelstat, their sole product candidate, is a potent and specific inhibitor of... 
More about the company
Surperformance© ratings of Geron Corporation
Trading Rating : Investor Rating :
More Ratings
Latest news on GERON CORPORATION
07:31a Geron to Present at the RBC Capital Markets Healthcare Conference
02/03 GERON CORPORATION : Biotechnology Stocks Technical Snapshot -- Geron, ACADIA Pha..
01/15 GERON : Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat i..
01/14 Geron Announces Initiation of Janssen Phase 2/3 Clinical Trial of Imetelstat ..
01/11 GERON : Results of Operations and Financial Condition, Regulation FD Disclosure,..
2015 GERON : Researchers from Stanford University Report Findings in Clinical Trials ..
2015 GERON CORPORATION : Traders Look to Upside - Free Research on Geron, MaxLinear, ..
2015 Geron Announces December Conference Presentation Webcasts
More news
Sector news : Bio Therapeutic Drugs
11:38a LONZA : and Renova Therapeutics Announce Manufacturing Agreement for Clinical Su..
05:04a PFIZER : Commends The FDA Advisory Committee's Vote To Approve Proposed Biosimil..
02/09DJPanel Recommends FDA Approval of Remicade Knockoff
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
01/26 NICK'S PICKS 2016 : Happily Overweight With Healthcare
01/12 GERON : What To Expect From Imetelstat Now
2015 PREMARKET BIOTECH DIGEST : Arrowhead's Potential, KaloBios Delisting, BiondVax P..
2015 A Closer Look At Johnson & Johnson's Collaboration With Geron
2015 GERON'S ASH PRESENTATIONS : What We Heard


Comments 
Advertisement
Chart GERON CORPORATION
Duration : Period :
Geron Corporation Technical Analysis Chart | GERN | US3741631036 | 4-Traders
Full-screen chart
Technical analysis trends GERON CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions